NM_000310.4:c.888G>A
Variant summary
Our verdict is Uncertain significance. The variant received 5 ACMG points: 5P and 0B. PVS1_ModeratePM2PP5
The NM_000310.4(PPT1):c.888G>A(p.Trp296*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000310.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- neuronal ceroid lipofuscinosisInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- neuronal ceroid lipofuscinosis 1Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), ClinGen, G2P, Orphanet, Myriad Women’s Health
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 5 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PPT1 | NM_000310.4 | c.888G>A | p.Trp296* | stop_gained | Exon 9 of 9 | ENST00000642050.2 | NP_000301.1 | |
| PPT1 | NM_001363695.2 | c.816G>A | p.Trp272* | stop_gained | Exon 8 of 8 | NP_001350624.1 | ||
| PPT1 | NM_001142604.2 | c.579G>A | p.Trp193* | stop_gained | Exon 6 of 6 | NP_001136076.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PPT1 | ENST00000642050.2 | c.888G>A | p.Trp296* | stop_gained | Exon 9 of 9 | NM_000310.4 | ENSP00000493153.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251384 AF XY: 0.00 show subpopulations
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Neuronal ceroid lipofuscinosis 1 Pathogenic:2
This sequence change creates a premature translational stop signal (p.Trp296*) in the PPT1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 11 amino acid(s) of the PPT1 protein. This variant is present in population databases (rs386833670, gnomAD 0.0009%). This premature translational stop signal has been observed in individual(s) with neuronal ceroid lipofuscinosis (PMID: 9664077). ClinVar contains an entry for this variant (Variation ID: 56219). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
- -
not provided Uncertain:1
Not observed in large population cohorts (Lek et al., 2016); Nonsense variant predicted to result in protein truncation as the last 11 amino acids are lost, although loss-of-function variants have not been reported downstream of this position in the protein; Reported in a patient with late-infantile NCL who harbored a second variant in PPT1; however, segregation analysis to determine phase was not provided (Das et al., 1998); Reported in a patient with late-infantile NCL who had reduced PPT protein level who harbored a second variant in PPT1; however, segregation analysis to determine phase of the variants was not provided (Das et al., 2001); This variant is associated with the following publications: (PMID: 8004106, 14997939, 12125808, 15965709, 9664077, 11440996, 10649502, 11332767, 11073228) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at